Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Fall -44.25% In Six Months, Here’s What We Should Expect Now
During the last session, Syndax Pharmaceuticals Inc (NASDAQ:SNDX)’s traded shares were 1.57 million, with the beta value of the company hitting 0.86. At the end